StemCell Manila
Patient coordinator Book Now
Book Now

Condition research · Knee osteoarthritis

Could stem cell therapy help knee osteoarthritis?

Human trials have studied mesenchymal stem cell injections for knee pain and function. The evidence is limited and does not establish that every cell source, dose, route, or clinic protocol will produce the same result.

Request a consultation Explore stem cell therapy

Condition overview

What knee osteoarthritis changes.

Knee osteoarthritis develops as cartilage and other tissues in the joint change and break down over time. It can cause pain with movement, stiffness after rest, swelling, reduced motion, or a feeling that the knee is unstable.

Symptoms and their effect on daily life vary from person to person, so a diagnosis and treatment discussion should account for the individual knee, current function, and care already tried.

Read the NIAMS osteoarthritis overview

Why people explore it

Less knee pain. Easier movement. More confidence staying active.

Those are understandable treatment hopes for someone living with osteoarthritis. They are not promised outcomes. A useful consultation should first confirm the diagnosis and compare established care with the exact cell-based option being discussed.

Research on one mesenchymal stem cell product cannot be applied automatically to another source, preparation, dose, route, or patient.

What the published research found

16 randomized trials involving 807 adults.

Research question
Do mesenchymal stem cell interventions improve pain and function for adults with chronic knee pain caused by osteoarthritis?
Population
Sixteen randomized trials involving 807 adults with chronic knee pain caused by osteoarthritis; ages and settings varied across trials.
Intervention
Intra-articular mesenchymal stem cell injections compared with placebo or usual care; cell sources, products, doses, and procedures varied across trials.
Study type
Systematic review and meta-analysis of randomized controlled trials.
Finding
At three to six months, the average pain difference was −0.74 cm on a 10 cm scale, below the 1.5 cm threshold the review used for an important difference. The average physical-function difference was 2.23 points on a 100-point scale, below the 10-point threshold. Any adverse event was more frequent (risk ratio 2.67), but certainty for harms was low.
Main limitation
The trials were heterogeneous and the certainty of evidence varied. The result is specific to knee osteoarthritis and cannot be transferred to another condition, cell source, route, or protocol.
Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials Sadeghirad B, Rehman Y, Khosravirad A, Sofi-Mahmudi A, Zandieh S, Jomy J, et al. Osteoarthritis and Cartilage. 2024.

Established alternatives

Stem cell therapy is not the only option.

Depending on the person and severity, established care may include exercise therapy, weight management where relevant, pain medicines, injections, assistive strategies, or surgery. A qualified clinician can explain the benefits and risks of each option.

A more useful treatment conversation

Make the proposed treatment specific.

  • Which exact cell source, product, preparation, dose, and route would be used?
  • Does human research match my diagnosis and the proposed protocol?
  • What are the common and serious risks, alternatives, total cost, and follow-up responsibilities?
  • Which outcome measures will show whether the treatment made a meaningful difference?

Independent patient resources

Philippines DOH Administrative Order 2013-0012

This 2013 order describes requirements for facilities using human stem cell and cell-based therapies in the Philippines. Confirm current DOH/FDA requirements, the facility, and the exact protocol against current records.

ISSCR Patient Handbook

Explains that established stem cell treatments are limited and gives patients questions to ask about evidence, oversight, risks, consent, cost, and follow-up.

This page is educational and does not establish treatment suitability or predict an individual outcome. A qualified clinician should assess knee symptoms, diagnosis, current care, risks, and the exact protocol.